Home » Topics » BioWorld Science, Cancer

BioWorld Science, Cancer
RSS

Protarga initiates multinational phase II program for Taxoprexin

June 7, 2001

New Celltech compounds useful for disease states associated with angiogenesis

June 7, 2001

Merck presents new series of indole-based tyrosine kinase inhibitors

June 7, 2001

GnRH antagonists useful for sex hormone-related disorders claimed by Neurocrine Biosciences

June 6, 2001

INGN-241: preclinical findings reported at American Society of Gene Therapy meeting

June 6, 2001

Intratumoral RPR/INGN-201 not associated with biosafety concerns in phase II trial

June 6, 2001

Thalomid/Xeloda combination to be evaluated for treatment of colorectal cancer

June 6, 2001

MVAC improves life expectancy in bladder cancer when administered prior to cystectomy

June 6, 2001

Abarelix depot shows good results in phase III prostate cancer studies

June 6, 2001

Prous Science inaugurates Advanced Internet TTMed Channel in Anaheim

June 5, 2001

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for July 30, 2026.
New schizophrenia targets challenge trial design
BioWorld
The search for better schizophrenia therapies is moving beyond dopamine toward a growing number of experimental targets. According to researchers, the repeated...
News in brief
BioWorld Asia
BioWorld Asia briefs for July 28, 2026
AIDS 2026: New targets for metabolic dysfunction despite ART
BioWorld
Although antiretroviral therapy (ART) can suppress HIV to undetectable levels, a growing body of evidence suggests that the virus leaves a lasting biological...
Fauci’s silence may put him in contempt of Congress
BioWorld
After repeatedly invoking the Fifth Amendment to every question asked during the July 29 hearing of the U.S. Senate Homeland Security Committee, Anthony Fauci,...